Eighty-five percent of diagnosed cases of lung cancer are non-small cell lung cancer (NSCLC). In this group, 5% of patients ...

The team from Cancer Research UK's Manchester Institute says it has created a new in vitro model of lung squamous cell ...

Dr. Lillian L. Siu discussed potential risk factors and treatment strategies associated for patients with head and neck ...

This week Bobbi Conner talks with Dr. Miriam Alexander about advances in lung cancer treatment in recent years. Dr. Alexander ...

Cancer Research scientists have developed a new cell-based model of lung squamous cell carcinoma (LUSC), a type of lung cancer, which has the potential to develop more effective treatments for the ...

A man died from lung cancer after doctors failed to spot a "red flag" lesion on an X-ray a year before he was diagnosed. John ...

New robotic surgery systems in Oklahoma are transforming the fight against lung cancer—the deadliest form. Discover how early ...

The U.S. Food and Drug Administration has approved Jobevne (bevacizumab-nwgd), a biosimilar to Avastin (bevacizumab) for ...

Discover how innovative lymphoma treatments are transforming patient outcomes, from targeted therapies to immunotherapy ...

Discover how cancer treatments impact heart health and learn strategies to mitigate cardiovascular risks during and after ...

In celebration of a decade of powerful advocacy and progress, LUNG FORCE Heroes—individuals personally impacted by lung ...